⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT February 4, 2026

Aprepitant Accord 80 mg Hartkapseln 80 mg (Hartkapsel)

📷 Wikipedia: Aprepitant · Source
Aprepitant Accord 80 mg Hartkapseln 80 mg (Hartkapsel)
📷 Wikipedia: Aprepitant · Source
Aprepitant Accord 80 mg hard capsules are delayed. Affected packs: boxes of 5 capsules and boxes of 2 capsules are currently limited. Supply is expected to resume on 31 October 2026.
🗄
Archived (older alert)
This alert was reported 219 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
116 days in total
May 18, 2026 September 11, 2026

What is this? Aprepitant Accord 80 mg is a medicine in capsules. It helps stop nausea and vomiting.

What's happening? There is a delay in making this medicine. Supplies are low in Austria.

Does this affect me? If you take this medicine in Austria, you may have trouble finding it.

What should I do? Ask your pharmacist or doctor for advice before running out.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
APREPITANT
Agency-published detail

ATC: A04AD12 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Accord Healthcare B.V., Winthontlaan 200, 3526 KV Utrecht, Niederlande · Affected packs: 5 Stück Schachtel, Blisterpackung [eingeschränkt verfügbar, since 2026-02-01, resupply 2026-10-31] · 2 Stück Schachtel, Blisterpackung [eingeschränkt verfügbar, since 2026-02-01, resupply 2026-10-31]

First published
February 4, 2026
Last refreshed by us
1 month ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 2 weeks ago

Aprepitant ratiopharm 80 mg/125 mg Hartkapseln 80 mg/125 mg (Hartkapsel)

Aprepitant ratiopharm 80 mg/125 mg hard capsules are subject to a parallel export ban.
Medium AT resolved 2 months ago

Aprepitant ratiopharm 125 mg Hartkapseln 125 mg (Hartkapsel)

Aprepitant ratiopharm 125 mg hard capsules are currently unavailable due to a delay in supply. Parallel export is prohibited.
High AT resolved 4 months ago

Aprepitant Sandoz 80 mg – Hartkapseln 80 mg (Hartkapsel)

Aprepitant Sandoz 80 mg hard capsules are not available in packs of 2 since May 11, 2026. Packs of 5 remain available.
High AT resolved 7 months ago

Aprepitant Accord 125 mg Hartkapseln 125 mg (Hartkapsel)

Aprepitant Accord 125 mg hard capsules are delayed in production.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Aprepitant Accord 80 mg Hartkapseln 80 mg (Hartkapsel). Aprepitant Accord 80 mg hard capsules are delayed. Affected packs: boxes of 5 capsules and boxes of 2 capsules are currently limited. Supply is expected to resume on 31 October 2026.
▸ When was this alert issued?
This alert was issued on February 4, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.